Results 351 to 360 of about 229,451 (392)

Effects of intracameral tissue plasminogen activator injection on posterior capsular opacification, fibrin formation, and intraocular pressure in dogs after phacoemulsification

Veterinary Ophthalmology, EarlyView.
Abstract Objective To evaluate whether intracameral tissue plasminogen activator (tPA) injection is effective in regulating posterior capsular opacification (PCO), fibrin formation and intraocular pressure (IOP) after cataract surgery. Animal Studied Prospective study involving 30 eyes of 21 dogs that underwent phacoemulsification.
Kyulee Kim, Young‐Sun Kang, Joon Young Kim   +2 more
wiley   +1 more source

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways. [PDF]

Cell Rep
Hirani R, Nandakumar S, Zaman N, Prabhakaraalva P, King SA, Kalidindi TM, Ghale R, Rajanala SH, Fidele DC, De Stanchina E, Mary Lee GS, Taplin ME, Balk SP, Sowalsky AG, Morris MJ, Kishore Pillarsetty NV, Stopsack KH, Gopalan A, Mucci LA, Kyprianou N, Tewari AK, Danila D, Kantoff PW, Chakraborty G.   +23 more
europepmc   +1 more source

Testosterone/androgen receptor antagonizes immobility-induced muscle atrophy through Inhibition of myostatin transcription and inflammation in mice. [PDF]

Sci Rep
Oura M, Son BK, Song Z, Toyoshima K, Nanao-Hamai M, Ogawa S, Akishita M.   +6 more
europepmc   +1 more source

Circulating microRNA profiles are associated with acute pain and stress in castrated and tail docked lambs. [PDF]

Vet Anim Sci
Farr RJ, Cowled C, Rodrigues C, Rootes CL, Campbell DLM, Lee C, Stewart CR, Marini D.   +7 more
europepmc   +1 more source

Immunomodulation and Immunotherapy for Patients with Prostate Cancer: An Up-to-Date Review. [PDF]

Biomedicines
Murray NP.
europepmc   +1 more source

rechARge: a randomized phase III trial of the androgen receptor ligand-directed degrader, BMS-986365, vs investigator's choice in patients with mCRPC. [PDF]

Future Oncol
Chi KN, McKay RR, Sandhu S, Arranz JA, Barthélémy P, Hadaschik B, Matsubara N, Shore ND, Ye D, Cascella T, Irincheeva I, Kreiser S, Thiery-Vuillemin A, Rathkopf DE.   +13 more
europepmc   +1 more source

Development of a predictive model for progression to castration-resistant prostate cancer in patients with high bone tumor burden. [PDF]

Am J Cancer Res
Chen W, Li J, A G, Huang S, Tang Y, Dong Y, Linghu X, Zhang H, Wang B, Guo P, Pan J.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Abiraterone and Olaparib for Metastatic Castration-Resistant Prostate Cancer.

NEJM Evidence, 2022
Abiraterone and Olaparib for Metastatic Prostate CancerPatients with metastatic castration-resistant prostate cancer, regardless of homologous recombination repair gene mutation status, received either abiraterone and olaparib or abiraterone and placebo ...
N. Clarke, A. Armstrong, A. Thiery-Vuillemin, M. Oya, N. Shore, E. Loredo, G. Procopio, J. de Menezes, G. Girotto, Ç. Arslan, N. Mehra, F. Parnis, E. Brown, F. Schlürmann, J. Joung, M. Sugimoto, J. Virizuela, U. Emmenegger, J. Navrátil, G. Buchschacher, C. Poehlein, E. Harrington, C. Desai, Jinyu Kang, F. Saad   +24 more
semanticscholar   +1 more source

To castrate or not to castrate? That is the question…

Veterinary Record, 2023
There is growing evidence that surgical castration of dogs may not bring all the benefits previously assumed. Times have changed too, and vets and clients are increasingly questioning whether routine castration should continue to be considered best practice.
openaire   +2 more sources